Related Experiment Video
Updated: Sep 14, 2025

Assessment of Vascular Tone Responsiveness using Isolated Mesenteric Arteries with a Focus on Modulation by Perivascular Adipose Tissues
Published on: June 3, 2019
Evaluating the Time of Maximal Vasoconstrictive Effect of Epinephrine in Facelift Surgery
Background:
It remains unclear how long a plastic surgeon should wait for the optimal vasoconstrictive effect of epinephrine as local anesthetic before incision for aesthetic facial surgery.
Objectives:
In this study we investigate the optimal timing for epinephrine-induced vasoconstriction in facelift procedures by measuring cheek skin temperature changes with forward-looking infrared thermography (FLIR).
Methods:
A retrospective chart review was conducted on all patients who underwent facelift surgery by J.E.Z. between July 2023 and June 2024. Skin surface temperature was recorded at baseline and at predetermined time points up to 15 minutes following injection of the standardized epinephrine-containing local anesthetic solution. Additional patient data were obtained from electronic medical record review.
Results:
Twenty-seven patients were included in the study. The median time for each patient to reach the lowest recorded cheek temperature was 5 minutes postinjection (mean 5.1 ± 2.9 minutes). Injected cheeks exhibited the largest median temperature decrease of 2.3°C at 7 minutes, followed by gradual rewarming to baseline. Uninjected nasal skin warmed steadily throughout the observation period. Of the 27 patients, 15 (55.6%) reached their minimum cheek temperature by 5 minutes, 23 (85.2%) by 7 minutes, and all 27 (100%) by 11 minutes.
Conclusions:
These findings demonstrate that the maximal vasoconstrictive effect of epinephrine in facelift surgery occurs approximately 5 to 7 minutes after injection. We recommend that facelift surgeons wait 5 to 7 minutes before initiating incisions and dissection to balance optimal hemostasis with procedural efficiency.
More Related Videos
19:53Single-stage Dynamic Reanimation of the Smile in Irreversible Facial Paralysis by Free Functional Muscle Transfer
Published on: March 1, 2015
04:48Noninvasive Determination of Vortex Formation Time Using Transesophageal Echocardiography During Cardiac Surgery
Published on: November 28, 2018
Related Concept Videos
Local Anesthetics: Pharmacokinetics
Adrenergic Agonists: Mixed-Action Agents
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
Adrenergic Agonists: Therapeutic Uses
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...